Andersen Global Debuts in Guadeloupe with InWest Avocats
Andersen Global continues to maintain its foothold in the Caribbean through a Collaboration Agreement with Guadeloupe-based law firm InWest Avocats, adding coverage to the southern edge of its presence in the region.
Founded in 2016 by Co-Founder and Managing Partner Frédéric Fanfant, InWest Avocats provides a range of legal services to both local and international businesses, institutions and associations. Based in Pointe-à-Pitre, the firm specializes in all areas of business law and provides customized solutions in commercial and corporate law, litigation, business contracts, real estate and taxation.
“Since the firm’s founding, we’ve focused on our clients’ success and have remained committed to providing our clients with best-in-class service through our team’s technical knowledge and dedication to stewardship,” Frédéric said. “Our firm’s collaboration with Andersen Global signifies not only our continued commitment to our clients, but further demonstrates our drive to deliver integrated solutions globally.”
“Frédéric, with new active partner Karine Dorville and InWest team, are aligned with our organization’s values and will work seamlessly with our professionals globally as we continue to offer clients comprehensive, seamless solutions,” Andersen Global Chairman and Andersen CEO Mark Vorsatz said. “The addition of InWest Avocats strengthens our existing coverage in the region as we advance our expansion strategy in the Caribbean.”
Andersen Global is an international association of legally separate, independent member firms comprised of tax and legal professionals around the world. Established in 2013 by U.S. member firm Andersen Tax LLC, Andersen Global now has more than 12,000 professionals worldwide and a presence in over 370 locations through its member firms and collaborating firms.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
S64 Bolsters Pioneering Team With Strategic Hires Amid Surging Demand for Private Markets Products29.9.2022 15:05:00 EEST | Press release
S64, the trusted alternatives partner to the world’s leading asset managers and private banks, has today announced a series of strategic hires following a period of rapid growth since its launch in 2020. S64’s best-in-class team, who worked together for over a decade at Deutsche Bank, has further strengthened its expertise by making a number of appointments from blue-chip institutions to its London office. The business also has plans to advance its footprint across EMEA, Asia and Australia in major global financial hubs. Strategic hires following rapid growth Led by founder and CEO Tarun Nagpal, S64’s team has led the way in industry innovation for more than a decade, pioneering the development of alternative platform solutions. The latest additions include Venkata Kota, Head of Client Solutions, formerly of Goldman Sachs and Deutsche Bank; Richard Marland, Head of Operations and Fund Governance, formerly of Deutsche Bank; Tetyana Turek, Business and Project Management, formerly of Deu
Strengthening Healthcare Systems to Meet Patients’ Need for Plasma-Derived Therapies29.9.2022 15:00:00 EEST | Press release
As part of their well-established partnership, the United Nations Institute for Training and Research (UNITAR) and Takeda (TSE:4502/NYSE:TAK), a global pharmaceutical leader and an active member of the United Nations Global Compact, are pleased to announce a new joint initiative focused on strengthening countries’ healthcare systems to meet patients’ need for plasma and plasma-derived therapies. The initiative will draw on UNITAR’s expertise in training and education toward the development of innovative solutions to global challenges and Takeda’s deep knowledge of rare disease and the plasma ecosystem. Global demand for plasma has greatly increased over the past 20 years and is continuing to grow due to increasing numbers of patients with rare diseases being diagnosed, as well as higher standards of care and broader access to treatment globally. This demand for life-changing and life-sustaining plasma-derived therapies far exceeds available supply, resulting in more people around the w
Adrestia appoints Will Lewis as Chair, establishes US Operations and appoints new functional leads29.9.2022 14:00:00 EEST | Press release
Adrestia Therapeutics, a leader in synthetic rescue therapies for genetic diseases, today announced that it appointed William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors, Jennifer Millian, M.S., M.B.A. as VP of U.S. Operations, and Philip Coxon, Ph.D., as VP of Business Development. This extends Adrestia’s presence to the United States and deepens its drug development capabilities as it moves its emerging pipeline of first-in-class therapeutics towards the clinic. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220928005044/en/ Will Lewis, Adrestia Chairman “Adrestia’s leading synthetic rescue platform is systematically mining the human genome to find new ways of treating patients with currently intractable diseases” said Lewis. “The team unites world-class biology and drug discovery leadership with an exciting vision for genetic medicine. We are discovering new biology that opens fresh ways of thinking about ta
Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia29.9.2022 13:54:00 EEST | Press release
Fluor Corporation (NYSE: FLR) announced today that the company has been selected by a leading biologics company to perform procurement and construction management for a large-scale biologics drug substance manufacturing facility located in Scandinavia. Fluor will book the multi-hundred-million-dollar reimbursable contract value in the third quarter of 2022. The facility will produce new capacity for advanced biologics that are used in a variety of treatments including vaccines, oncology and quality-of-life medicines. Fluor has performed the planning and enabling work for this project, and construction is now underway with the facility scheduled to be operational by 2025. Fluor’s Advanced Technologies & Life Sciences business is leading the project including support from its Nordic Technology Hub in Copenhagen, Denmark. About Fluor Corporation Fluor Corporation (NYSE: FLR) is building a better future by applying world-class expertise to solve its clients’ greatest challenges. Fluor’s 41
Versace Chooses Board to Transform Retail Planning29.9.2022 13:22:00 EEST | Press release
Board, the leading global provider of Intelligent Planning Solutions which help organizations plan smarter — enabling actionable insights and better outcomes, today announced that Versace, the Italian fashion house that symbolizes luxury worldwide, has chosen Board to transform its Retail Planning. The Versace Group distributes its products through a direct network of over 200 owned boutiques and 1,500 distributors worldwide, with a turnover of more than one billion euros. Due to evolving challenges of global sourcing and the change in consumer purchasing habits, Versace recently revamped its retail strategy by opening new stores, strengthening their multi-channel approach and increasing investments in the efficiency of crucial business planning processes. "Board’s Intelligent Planning platform, provides the flexible and easy to use solutions necessary to support the innovation and growth of our brand,” said Francesco Loporcaro, IT Manager at Versace “Our selection of Board was influen
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom